Key result
Coronary endarterectomy performed adjacent to CABG for diffuse coronary artery disease was associated with an operative mortality of 5% and a transient rise in cardiac biomarkers.
Why the study?
The purpose of coronary endarterectomy adjacent to CABG in diffuse coronary artery disease remains controversial, prompting evaluation of its operative outcomes, safety, and complications.
Does coronary endarterectomy adjacent to CABG provide safe and complete revascularization in patients with diffuse coronary artery disease?
Observational (n=100)
No
Does coronary endarterectomy adjacent to CABG provide safe and complete revascularization in patients with diffuse coronary artery disease?
Answers are grounded in this paper and cite their sources.
Coronary endarterectomy alongside CABG is associated with a transient rise in cardiac biomarkers and a 5% operative mortality, supporting its use as a viable strategy for complete revascularization in diffuse coronary artery disease.
Background and Aim of the Study: Coronary endarterectomy (CE) is performed adjacent to coronary artery bypass grafting (CABG) grafting to aid complete revascularization. However, the purpose of CE in surgical management of diffuse coronary artery disease (CAD) is controversial. The objective of this study was to highlight the operative outcomes, safety, and complications associated with CE. Methods: An observational, prospective research was carried out in the Department of Cardiovascular and Thoracic Surgery at our institute. All patients undergoing isolated CABG + CE from 2019 till 2021 were evaluated. Patients undergoing urgent, emergency, or elective CABG + CE off-pump/on-pump surgery were enrolled. Results: One hundred patients with CABG + CE were evaluated based on symptomatology with sequential electrocardiogram monitoring and blood samples for cardiac biomarkers. The blood samples were taken 6, 12, 24, 48, and 72 h following surgery. Eighty-five patients required single CE and 15 patients required double CE. We noticed a rising trend of cardiac markers in the first 6 h, reaching its peak level at 24 h, and downward trend following 72 h following surgery. Although patients had a tremendous rise in the cardiac biomarker values, clinically patients were stable with operative mortality of 5%. Conclusions: We believe CE helps in complete revascularization in patients with diffuse CAD. CE should be given due consideration in an era where it has been neglected due to its complexities and accompanying myths. CE is an important and integral weapon in a surgeon's armamentarium, and we should not hesitate to perform CE due to associated myths.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2022) conducted an observational in Diffuse coronary artery disease (CAD) (n=100). Coronary endarterectomy (CE) + CABG was evaluated on Operative mortality. Coronary endarterectomy performed adjacent to CABG for diffuse coronary artery disease was associated with an operative mortality of 5% and a transient rise in cardiac biomarkers.
Synapse has enriched 10 related papers. Consider them for comparative context: